EKF Diagnostics, the global in vitro diagnostics company, announces that a recent study has confirmed that its Quo-Test® A1c point-of-care testing (POCT) analyzer shows comparable performance to a lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback